Transfusion in the Absence of Inflammation Induces Antigen-specific Tolerance to Murine RBCs

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2011 Nov 15

PMID 22077064

Citations 28

Authors

Nicole H Smith

Eldad A Hod

Steven L Spitalnik

James C Zimring

Jeanne E Hendrickson

Affiliations

Soon will be listed here.

Abstract

Most human transfusion recipients fail to make detectable alloantibodies to foreign RBC antigens ("nonresponders"). Herein, we use a murine model to test the hypothesis that nonresponders may be immunologically tolerant. FVB mice transfused with RBCs expressing transgenic human glycophorin A (hGPA) antigen in the absence of inflammation produced undetectable levels of anti-hGPA immunoglobulins, unlike those transfused in the presence of polyinosinic:polycytidylic acid-induced inflammation. Mice in the nonresponder group failed to produce anti-hGPA after subsequent transfusions in the presence of polyinosinic:polycytidylic acid, whereas anti-hGPA levels increased in the responder group. This tolerance was antigen specific, because nonresponders to hGPA produced alloantibodies to RBCs that expressed a different transgenic antigen. This tolerance was not an idiosyncrasy of the hGPA antigen nor of the recipient strain, because B10.BR mice transfused with membrane-bound hen egg lysozyme antigen-transgenic RBCs also demonstrated induced nonresponsiveness. These data demonstrate that RBCs transfused in the absence of inflammation can induce tolerance.

Citing Articles

Harnessing the potential of red blood cells in immunotherapy.

Jajosky R, Zerra P, Chonat S, Stowell S, Arthur C Hum Immunol. 2024; 85(6):111084.

PMID: 39255557 PMC: 11808826. DOI: 10.1016/j.humimm.2024.111084.

Alloantigen Copy Number as a Critical Factor in RBC Alloimmunization.

Patel S, Maier C, Zimring J Transfus Med Rev. 2023; 37(1):21-26.

PMID: 36725483 PMC: 10023450. DOI: 10.1016/j.tmrv.2022.12.009.

Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice.

Jajosky R, Patel S, Wu S, Patel K, Covington M, Vallecillo-Zuniga M Blood. 2023; 141(21):2642-2653.

PMID: 36638335 PMC: 10356576. DOI: 10.1182/blood.2022016588.

The Development and Consequences of Red Blood Cell Alloimmunization.

Arthur C, Stowell S Annu Rev Pathol. 2022; 18:537-564.

PMID: 36351365 PMC: 10414795. DOI: 10.1146/annurev-pathol-042320-110411.

Anti-JMH alloantibody in inherited JMH-negative patients leads to immunogenic destruction of JMH-positive RBCs.

Yuan Z, Wei Y, Chen X, He S, Cai K, Zhong M Clin Exp Immunol. 2021; 205(2):182-197.

PMID: 34021913 PMC: 8274163. DOI: 10.1111/cei.13622.

References

Grewal I, Moudgil K, Sercarz E . Hindrance of binding to class II major histocompatibility complex molecules by a single amino acid residue contiguous to a determinant leads to crypticity of the determinant as well as lack of response to the protein antigen. Proc Natl Acad Sci U S A. 1995; 92(5):1779-83. PMC: 42603. DOI: 10.1073/pnas.92.5.1779. View

Matzinger P . The danger model: a renewed sense of self. Science. 2002; 296(5566):301-5. DOI: 10.1126/science.1071059. View

Frohn C, Dumbgen L, Brand J, Gorg S, Luhm J, Kirchner H . Probability of anti-D development in D- patients receiving D+ RBCs. Transfusion. 2003; 43(7):893-8. DOI: 10.1046/j.1537-2995.2003.00394.x. View

Higgins J, Sloan S . Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood. 2008; 112(6):2546-53. DOI: 10.1182/blood-2008-03-146415. View

Hendrickson J, Chadwick T, Roback J, Hillyer C, Zimring J . Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood. 2007; 110(7):2736-43. DOI: 10.1182/blood-2007-03-083105. View

Yu J, Heck S, Yazdanbakhsh K . Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models. Am J Hematol. 2007; 82(8):691-6. PMC: 3607942. DOI: 10.1002/ajh.20959. View

Seyfried H, WALEWSKA I . Analysis of immune response to red blood cell antigens in multitransfused patients with different diseases. Mater Med Pol. 1990; 22(1):21-5. View

Zimring J, Hair G, Chadwick T, Deshpande S, Anderson K, Hillyer C . Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood. 2005; 106(3):1105-12. DOI: 10.1182/blood-2005-03-1040. View

Cox J, Steane E, Cunningham G, Frenkel E . Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med. 1988; 148(11):2485-9. View

10.

Tormey C, Fisk J, Stack G . Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Transfusion. 2008; 48(10):2069-76. DOI: 10.1111/j.1537-2995.2008.01815.x. View

11.

Noizat-Pirenne F, Tournamille C, Bierling P, Roudot-Thoraval F, Le Pennec P, Rouger P . Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion. 2006; 46(8):1328-33. DOI: 10.1111/j.1537-2995.2006.00900.x. View

12.

Gunson H, STRATTON F, Cooper D, RAWLINSON V . Primary immunization of Rh-negative volunteers. Br Med J. 1970; 1(5696):593-5. PMC: 1699618. DOI: 10.1136/bmj.1.5696.593. View

13.

Yazer M, Triulzi D . Detection of anti-D in D- recipients transfused with D+ red blood cells. Transfusion. 2007; 47(12):2197-201. DOI: 10.1111/j.1537-2995.2007.01446.x. View

14.

Auffray I, Marfatia S, de Jong K, Lee G, Huang C, Paszty C . Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice. Blood. 2001; 97(9):2872-8. DOI: 10.1182/blood.v97.9.2872. View

15.

Rosse W, Gallagher D, Kinney T, Castro O, Dosik H, Moohr J . Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood. 1990; 76(7):1431-7. View

16.

Bao W, Yu J, Heck S, Yazdanbakhsh K . Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice. Blood. 2009; 113(22):5624-7. PMC: 4729534. DOI: 10.1182/blood-2008-12-193748. View

17.

Aygun B, Padmanabhan S, Paley C, Chandrasekaran V . Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion. 2002; 42(1):37-43. DOI: 10.1046/j.1537-2995.2002.00007.x. View

18.

Hendrickson J, Desmarets M, Deshpande S, Chadwick T, Hillyer C, Roback J . Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion. 2006; 46(9):1526-36. DOI: 10.1111/j.1537-2995.2006.00946.x. View

19.

Hartley S, Crosbie J, Brink R, Kantor A, Basten A, Goodnow C . Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature. 1991; 353(6346):765-9. DOI: 10.1038/353765a0. View

20.

Schonewille H, van de Watering L, Brand A . Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?. Transfusion. 2006; 46(4):630-5. DOI: 10.1111/j.1537-2995.2006.00764.x. View